Literature DB >> 18981443

Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia.

David B Hogan1, Peter Bailey, Sandra Black, Anne Carswell, Howard Chertkow, Barry Clarke, Carole Cohen, John D Fisk, Dorothy Forbes, Malcolm Man-Son-Hing, Krista Lanctôt, Debra Morgan, Lilian Thorpe.   

Abstract

BACKGROUND: Practising physicians frequently seek advice on the most effective interventions for dementia. In this article, we provide practical guidance on nonpharmacologic and pharmacologic interventions for the management of mild to moderate dementia based on recommendations from the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia.
METHODS: We developed evidence-based guidelines using systematic literature searches, with specific criteria for the selection and quality assessment of articles, and a clear and transparent decision-making process. We selected articles published from January 1996 to December 2005 that dealt with the management of mild to moderate stages of Alzheimer disease and other forms of dementia. Recommendations based on the literature review were drafted and voted on. Consensus required 80% or more agreement by participants. Subsequent to the conference, we searched for additional articles published from January 2006 to April 2008 using the same major keywords and secondary search terms. We graded the strength of the evidence using the criteria of the Canadian Task Force on Preventive Health Care.
RESULTS: We identified 1615 articles, of which 954 were selected for further study. From a synthesis of the evidence in these studies, we made 48 recommendations for the management of mild to moderate dementia (28) and dementia with a cerebrovascular component (8) as well as recommendations for addressing ethical issues (e.g., disclosure of the diagnosis) (12). The updated literature review did not change these recommendations. An exercise program is recommended for patients with mild to moderate dementia. Physicians should decide whether to prescribe a cholinesterase inhibitor on an individual basis, balancing anticipated benefits with the potential for harm. For mild mood and behavioural concerns, nonpharmacologic approaches should be considered first.
INTERPRETATION: Although the available therapies for dementia can help with the management of symptoms, there is a need to develop more effective interventions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981443      PMCID: PMC2572644          DOI: 10.1503/cmaj.081103

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  56 in total

1.  Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

Authors:  C Courtney; D Farrell; R Gray; R Hills; L Lynch; E Sellwood; S Edwards; W Hardyman; J Raftery; P Crome; C Lendon; H Shaw; P Bentham
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

2.  The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease.

Authors:  P M Doraiswamy; L Kaiser; F Bieber; R L Garman
Journal:  Alzheimer Dis Assoc Disord       Date:  2001 Oct-Dec       Impact factor: 2.703

3.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

4.  Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial.

Authors:  Yves Rolland; Fabien Pillard; Adrian Klapouszczak; Emma Reynish; David Thomas; Sandrine Andrieu; Daniel Rivière; Bruno Vellas
Journal:  J Am Geriatr Soc       Date:  2007-02       Impact factor: 5.562

5.  Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial.

Authors:  Susan M McCurry; Laura E Gibbons; Rebecca G Logsdon; Michael V Vitiello; Linda Teri
Journal:  J Am Geriatr Soc       Date:  2005-05       Impact factor: 5.562

6.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

Review 7.  Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia.

Authors:  David B Hogan; Peter Bailey; Sandra Black; Anne Carswell; Howard Chertkow; Barry Clarke; Carole Cohen; John D Fisk; Dorothy Forbes; Malcolm Man-Son-Hing; Krista Lanctôt; Debra Morgan; Lilian Thorpe
Journal:  CMAJ       Date:  2008-10-07       Impact factor: 8.262

8.  Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment.

Authors:  Brian D Carpenter; Chengjie Xiong; Emily K Porensky; Monica M Lee; Patrick J Brown; Mary Coats; David Johnson; John C Morris
Journal:  J Am Geriatr Soc       Date:  2008-01-05       Impact factor: 5.562

Review 9.  Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review.

Authors:  Andrew Clegg; Jackie Bryant; Tricia Nicholson; Linda McIntyre; Sofie De Broe; Karen Gerard; Norman Waugh
Journal:  Int J Technol Assess Health Care       Date:  2002       Impact factor: 2.188

Review 10.  Cholinesterase inhibitors for Alzheimer's disease.

Authors:  J Birks
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25
View more
  38 in total

1.  Behaviour management in dementia.

Authors:  Peter Kapusta; Loren Regier; Julia Bareham; Brent Jensen
Journal:  Can Fam Physician       Date:  2011-12       Impact factor: 3.275

2.  The "Rising Tide" of dementia in Canada: What does it mean for pharmacists and the people they care for?

Authors:  Feng Chang; Tejal Patel; Mary E Schulz
Journal:  Can Pharm J (Ott)       Date:  2015-07

Review 3.  Withdrawal of Antidementia Drugs in Older People: Who, When and How?

Authors:  Carole Parsons
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

Review 4.  How applicable are clinical practice guidelines to elderly patients with comorbidities?

Authors:  Donatus R Mutasingwa; Hong Ge; Ross E G Upshur
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

5.  Curing and caring: the work of primary care physicians with dementia patients.

Authors:  Ester Carolina Apesoa-Varano; Judith C Barker; Ladson Hinton
Journal:  Qual Health Res       Date:  2011-06-17

6.  Dementia: What pharmacists need to know.

Authors:  Silvia Duong; Tejal Patel; Feng Chang
Journal:  Can Pharm J (Ott)       Date:  2017-02-07

Review 7.  Care of community-dwelling older adults with dementia and their caregivers.

Authors:  Natalie Warrick; Jeanette C Prorok; Dallas Seitz
Journal:  CMAJ       Date:  2018-07-03       Impact factor: 8.262

8.  Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.

Authors:  Chit Wai Wong
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

Review 9.  An update on the diagnosis and management of dementing conditions.

Authors:  Marwan Maalouf; John M Ringman; Jiong Shi
Journal:  Rev Neurol Dis       Date:  2011

10.  Optimal management of Alzheimer's disease patients: Clinical guidelines and family advice.

Authors:  Julia Haberstroh; Harald Hampel; Johannes Pantel
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-25       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.